Eterna Therapeutics
ERNA
$1.71
Share price
-3.93%
Change (1 day)
-44.84%
Change (1 year)
Categories
Eterna Therapeutics (ERNA) - Cash on Hand
Cash on Hand as of December 2023 : $7.57 M
According to Eterna Therapeutics's latest financial reports the company has $7.57 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Eterna Therapeutics - Cash on Hand chart (from 2020 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $11.44 M | -32.61% |
| 2021-12-31 | $16.98 M | 942.02% |
| 2020-12-31 | $1.63 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $9.92 B | 130,964.55% | 🇫🇷 France |
 Baxter BAX | $3.19 B | 42,065.02% | 🇺🇸 USA |
 Omeros Corporation OMER | $0.31 B | 3,996.50% | 🇺🇸 USA |
 Geron GERN | $0.33 B | 4,305.27% | 🇺🇸 USA |
 Genetic Technologies GENE | $2.54 M | -66.42% | 🇦🇺 Australia |
 Teva Pharmaceutical Industries TEVA | $3.22 B | 42,487.46% | 🇮🇱 Israel |
 Bio-Techne TECH | $0.13 B | 1,690.79% | 🇺🇸 USA |